Correction to: Nature https://doi.org/10.1038/s41586-021-03990-6 Published online 30 June 2021
In this version of this Article originally published, there were errors in Fig. 2 and in the references list. Specifically, in the Fig. 2c colour key, the middle cyan key now reading “JNJ-A07, 10 mg per kg, b.i.d” was missing the number of units, “10,” in the originally published version. Further, refs. 27 and 28 were swapped in the references list; their correct order appears below. The original Article has been corrected online.
References
Low, J. G., Ooi, E. E. & Vasudevan, S. G. Current status of dengue therapeutic research and development. J. Infect. Dis. 215, S96–S102 (2017).
Unlocking the Potential of Preventive Therapies for Malaria. World Health Organization, https://www.who.int/malaria/media/preventive-therapies/en/ (7 April 2017).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kaptein, S.J.F., Goethals, O., Kiemel, D. et al. Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction. Nature 599, E2 (2021). https://doi.org/10.1038/s41586-021-04123-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-021-04123-9
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
